Monday, August 26, 2019

Optical Coherence Tomography Market Set for Rapid Growth During 2026

New York, NY 26 Aug 2019 The Global Optical Coherence Tomography Market (OCT) Size is anticipated to reach over USD 2,179.75 Million by 2026 according to a new research published by Polaris Market Research. Optical Coherence Tomography (OCT) methods are operative optical diagnostics techniques that cast a 2D as well as the 3D outlook of the retina to help ophthalmological assessments and treatments.  The Optical Coherence Tomography (OCT) Market is basically impelled by the differential need for these methods across several areas of life science and healthcare. The OCT market has been emphasized by the advancement in technologies, furthered by the increasing significance of medical applications in the current scenario.

The range of Optical Coherence Tomography is not limited to ophthalmology and has extended across other medical application such as nephrology, dermatology, and oncology. This factor has amplified the growth scenarios of the Optical Coherence Tomography (OCT) which is anticipated to show intense growth in the forecast period.  The escalation of pathology has also become a devoted contributor to market growth as OCT methods could be employed in the pensive study of micro-level diseases. Furthermore, the non-intrusive nature of OCT has made this technique a prime choice of the medical community for ophthalmic imaging.


The Optical Coherence Tomography (OCT) market has extended its area to the study of ailments such as cardiovascular disruptions, diabetes, esophageal problems, non-melanoma skin cancer, and prostate cancer. This is a significant standpoint for the market as the increasing occurrence of such disorders would create a widespread demand for OCT products. In addition, the emerging economies such as China, Japan, and India have seen operational variations in their healthcare sector which is making developing progress in that regions. This proliferates the demand for OCT devices further propelling the market growth.

 Some major key players in global Optical Coherence Tomography (OCT) Market include Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Topcon Medical Systems Inc. and Thorlabs Inc. among others.
  
The global Optical Coherence Tomography (OCT) Market is segmented on the basis of technology, type, application, and geography. On the basis of technology, the global Optical Coherence Tomography (OCT) Market is segmented into Time Domain Optical Coherence Tomography (TDOCT), Frequency Domain Optical Coherence Tomography (FD-OCT), and Spatially Encoded Frequency Domain Optical Coherence Tomography. The Spatially Encoded Frequency Domain Optical Coherence Tomography is further categorized into Spectral Domain Optical Coherence Tomography (SDOCT) and Fourier Domain Optical Coherence Tomography (FDOCT).

On the basis of type, the global Optical Coherence Tomography (OCT) Market is segmented into Catheter-based OCT devices, Doppler OCT devices, Handheld OCT devices, and Tabletop OCT devices. In 2017, the handheld type segment was estimated to dominate the market. The dominance is attributed to the higher product penetration in developed regions such as U.S., U.K., Germany, and Brazil.

  
On the basis of application, the global Optical Coherence Tomography (OCT) Market is segmented into Ophthalmology, Cardiovascular, Oncology, Dermatology, and others. In 2017, ophthalmology segment is estimated to dominate the market growth. Introduction of higher performing devices with accurateness, improved performance, and easiness of use coupled with the supplementing occurrences of choroidal and retinal disorders is the vigorous impact rendering factor enhancing the market growth.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world


Narcolepsy Therapeutics Global Market Outloo 2025 by Research,Trends and Future Prospects

New York, NY 26 Aug 2019 The Global Narcolepsy Therapeutics Market is anticipated to reach over USD 3263.65 Million by 2025 according to a new research published by Polaris Market Research.

Narcolepsy is a therapeutic disorder which is categorized by prodigious daytime sleepiness as well as sudden attacks of sleep. In some cases, this chronic sleep disease can lead to an abrupt loss of muscle tone (cataplexy), leading to loss and weakness of muscle control. Some of the most common indications of narcolepsy are daytime sleepiness, hallucinations, fragmented sleep & insomnia, and sleep paralysis.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/request-for-sample

Growing incidence of narcolepsy and increasing overweight populace are the major factors estimated to drive the global narcolepsy therapeutics market growth. For instance, according to the Sleep Science journal 2017 report, it was estimated that around 1 in every 2,000 people across the globe are suffering from narcolepsy disorder. Moreover, according to the Australian Institute of Health and Welfare, around 63% of the Australian individuals who are aged over 18 years were estimated to be obese or overweight. Additionally, growing research and development activities and growing demands for effective treatment of the disease are another factors expected to boost the market growth. However, low per capita healthcare spending and lack of awareness majorly in middle income and lower-income economies is estimated to hinder the global narcolepsy therapeutics market during the forecast period.

Some major key players in global Narcolepsy Therapeutics Market include Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. among others

The global Narcolepsy Therapeutics Market is segmented on the basis of product, type, and geography. On the basis of product, the global Narcolepsy Therapeutics Market is segmented into Sodium Oxybate, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, and Tricyclic Antidepressants. In 2017, Sodium oxybate was estimated to domkiat5e the market segment. The dominance is due to the presence of favorable reimbursement guidelines, the high cost of this drug, and the increasing awareness levels relating to diagnosis & associated treatments of the disease. On the basis of type, the global Narcolepsy Therapeutics Market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. In 2017, the Narcolepsy with cataplexy segment was estimated to dominate the market growth. The dominance is attributed to the growing incidence of cataplexy as a major indication in patients.

Request for discount on this market study 
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/request-for-discount-pricing

On the basis of region, the global Narcolepsy Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe was estimated to dominate the global Narcolepsy Therapeutics Market. The dominance is majorly attributed to the well-established healthcare organizations, rising R&D initiatives for the expansion of novel drugs, and high incidence of people suffering from such disorder. However, Asia Pacific is expected to dominate the global Narcolepsy Therapeutics Market during the forecast. Rising disposable income, increasing investments in biotechnology and pharmaceutical sectors, economic development, supportive government initiatives, and rising awareness among people regarding the appropriate therapies are the factors expected to significantly boost the Narcolepsy Therapeutics Market in the Asia Pacific.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us